Helen E. Bryant

Papers

Total Citations

H-Index

About

Helen E. Bryant is a clinical researcher whose work centers on patient-centered outcomes in prostate cancer, with a particular focus on the methodological and ethical challenges of randomized controlled trials. Her most notable contribution is the landmark study "Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence)" (2013), which demonstrated that men with prostate cancer are willing to accept randomization in comparative effectiveness research—a finding that has shaped trial design in urologic oncology. This work, cited 8 times, has been instrumental in advancing evidence-based decision-making for prostate cancer treatments. Bryant’s research bridges the gap between clinical trial methodology and real-world patient preferences, ensuring that comparative studies reflect genuine patient perspectives. Her contributions have helped validate the feasibility of large-scale pragmatic trials, ultimately improving the quality of evidence available to clinicians and patients. Through her rigorous approach, Bryant has established herself as a key voice in the ongoing effort to make clinical research more inclusive and patient-driven.